Decreased mortality in cancer patients treated for proximal deep vein thrombosis with low-molecular-weight heparin as compared with unfractionated heparin

被引：0
|
作者：
Pineo, GF [1 ]
Hull, RD [1 ]
Raskob, GE [1 ]
Brant, RF [1 ]
Green, D [1 ]
机构：
[1] UNIV CALGARY, CALGARY, AB T2N 1N4, CANADA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：O1566 / O1566
页数：1
相关论文
共 50 条
  • [41] Transaminase elevation in patients with unfractionated heparin or low molecular weight heparin for deep venous thrombosis
    Rossi, L
    Girolami, B
    Villalta, S
    Scarano, L
    Marchiori, A
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1163 - P1163
  • [42] COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH INTRAVENOUS STANDARD HEPARIN IN PROXIMAL-VEIN THROMBOSIS
    PRANDONI, P
    LENSING, AWA
    BULLER, HR
    CARTA, M
    COGO, A
    TENCATE, JW
    THROMBOSIS RESEARCH, 1993, 70 : S51 - S51
  • [43] COMPARISON OF A LOW-MOLECULAR WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN AND UNFRACTIONATED HEPARIN FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING ABDOMINAL-SURGERY
    ENCKE, A
    BRITISH JOURNAL OF SURGERY, 1988, 75 (11) : 1058 - 1063
  • [44] Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients
    Levine, M
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 : 9 - 11
  • [45] LOW-MOLECULAR WEIGHT HEPARIN COMPARED WITH UNFRACTIONATED HEPARIN IN PREVENTION OF POSTOPERATIVE THROMBOSIS
    SAMAMA, M
    BERNARD, P
    BONNARDOT, JP
    COMBETAMZALI, S
    LANSON, Y
    TISSOT, E
    BRITISH JOURNAL OF SURGERY, 1988, 75 (02) : 128 - 131
  • [46] Cost-effectiveness of low-molecular weight heparin and unfractionated heparin in treatment of deep vein thrombosis
    Rodger, M
    Bredeson, C
    Wells, PS
    Beck, J
    Kearns, B
    Huebsch, LB
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1998, 159 (08) : 931 - 938
  • [47] Low-molecular-weight heparin in thrombosis and cancer
    Mousa, SA
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 : 25 - 30
  • [48] Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
    Volteas, Panagiotis
    Drakos, Panagiotis
    Alkadaa, Leor N.
    Cleri, Nathaniel A.
    Asencio, Anthony A.
    Oganov, Anthony
    Giannopoulos, Stefanos
    Saadon, Jordan R.
    Mikell, Charles B., III
    Rubano, Jerry A.
    Labropoulos, Nicos
    Tassiopoulos, Apostolos K.
    Mofakham, Sima
    Bannazadeh, Mohsen
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (05) : 1128 - 1136
  • [49] Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis
    Belcaro, G
    Nicolaides, AN
    Cesarone, MR
    Laurora, G
    De Sanctis, MT
    Incandela, L
    Barsotti, A
    Corsi, M
    Vasdekis, S
    Christopoulos, D
    Lennox, A
    Malouf, M
    ANGIOLOGY, 1999, 50 (10) : 781 - 787
  • [50] Is low-molecular-weight heparin the answer for the therapy of acute deep vein thrombosis?
    Vouyouka, A
    Silver, D
    VASCULAR SURGERY, 1999, 33 (02): : 125 - 128
12345